Diagnostics
Whole-body 3T MRI. Two-hundred-marker bloodwork. DEXA composition. VO₂ max with lactate threshold. Continuous glucose monitor. Hormone panels at depth. Coronary calcium. Microbiome. Epigenetic age clocks.
Independent reviews of 19 longevity programmes across Europe, the Gulf, North America and Asia. Scored 0–100 against a four-axis editorial rubric. No paid placements. No partnerships. Read first, then book.
Longevity medicine is the branch of clinical practice that treats *staying well* as the work itself, rather than as the absence of disease. The standard menu is wide and getting wider. The standard answer to what should I actually do is harder to find than the menu.
Whole-body 3T MRI. Two-hundred-marker bloodwork. DEXA composition. VO₂ max with lactate threshold. Continuous glucose monitor. Hormone panels at depth. Coronary calcium. Microbiome. Epigenetic age clocks.
Hormone optimisation. Targeted peptides. NAD+ infusions. Hyperbaric oxygen. IV nutrient infusions. Cryotherapy. Pulsed electromagnetic field. Off-label pharmacology, in clinics willing to prescribe.
Sleep architecture. Resistance training prescription. Zone-2 cardio. Nutritional periodisation. Stress and recovery protocols. Continuity care, the part most clinics under-deliver on. The part that decides whether the cheque was worth it.
The market divides cleanly into three formats with different jobs to do, different cost bases, and different patients they suit. Choose the format before you choose the clinic.
Multi-day to multi-week stays. Diagnostics, treatments and supervised recovery delivered together, on one campus, with a single clinical team. Switzerland still defines the genre.
Single-day diagnostics with structured follow-up. The faster, sharper, cheaper format. Berlin, London and Singapore lead on diagnostic depth. The work happens in the year that follows the day.
Annual concierge memberships that bundle diagnostics, longitudinal protocol design and quarterly clinician contact. The dominant US model and the format with the strongest continuity-of-care argument.
Six programmes that define the upper edge of the field today. Each earns the price for a different patient. None earns it for everyone.
The clearest answer in Europe to the question — what do I actually need? Comprehensive same-day diagnostics, MD-led, no in-house treatment upsell. Our editorial pick for best overall.
Peter Attia's clinical home, opened publicly in 2025. Diagnostic depth on a par with YEARS, a longitudinal membership model, and an editorial leaning towards Medicine 3.0 — risk stratification across cardiovascular, metabolic, brain, cancer and quality-of-life axes.
Peter Attia's private clinical practice — small, MD-led, currently closed to new patients. The clinical home from which Medicine 3.0 was authored.
Co-founded by Peter Diamandis and J. Craig Venter in 2013 — the institutional pioneer of genome-plus-imaging executive health. Ten-plus years of methodology refinement, AI-augmented MRI reading, and a serious genomics back-end.
Diamandis-Robbins-Hariri's flagship preventive-medicine network. Whole-body MRI plus AI-cardiac imaging plus genome sequencing built around a strong early-detection thesis. Five US locations and growing; the structural conflict is the membership treatment ladder that follows.
The world's first dedicated longevity center inside a major academic hospital. Strong diagnostic infrastructure, hospital-grade safety net, and an active research programme behind the patient-facing clinic.
What this category costs, what it does and doesn't deliver, what we do and don't take a position on.
“Compare quietly. Choose well.
— The editorial position, since the first review